Promising new treatment for pancreatic cancer doubles survival rates

Researchers have made a significant leap forward in battling pancreatic cancer, a disease notorious for its rapid progression and poor prognosis. An experimental drug, taken daily, has shown to double survival rates by effectively slowing the cancer's advance. This breakthrough comes after decades of research and offers newfound hope to patients and their families. With experts like Dr. Rachna Shroff championing this advancement, it's clear that this development could fundamentally change the outlook for those diagnosed with this aggressive form of cancer.